Maravai LifeSciences Holdings, Inc.

NasdaqGS:MRVI Stok Raporu

Piyasa değeri: US$2.0b

Maravai LifeSciences Holdings Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Maravai LifeSciences Holdings şirketinin kazançları yıllık ortalama -28.8% oranında azalırken, Life Sciences sektörünün kazançları yıllık 12.7% oranında artan oldu. Gelirler yıllık ortalama 28.2% oranında azalan oldu.

Anahtar bilgiler

-28.8%

Kazanç büyüme oranı

-53.0%

EPS büyüme oranı

Life Sciences Sektör Büyümesi21.5%
Gelir büyüme oranı-28.2%
Özkaynak getirisi-20.9%
Net Marj-47.4%
Sonraki Kazanç Güncellemesi07 Nov 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet?

Oct 15
Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet?

Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) 29% Jump Shows Its Popularity With Investors

Jul 18
Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) 29% Jump Shows Its Popularity With Investors

Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet?

Jul 15
Does Maravai LifeSciences Holdings (NASDAQ:MRVI) Have A Healthy Balance Sheet?

Maravai: Embedded Expectations Remain Too High Considering Economic Calculus

Jul 12

RGA Investment Advisors - Maravai: Two Elite Assets With Other-Worldly Margins Wrapped In One

Jun 12

Revenues Tell The Story For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) As Its Stock Soars 25%

May 14
Revenues Tell The Story For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) As Its Stock Soars 25%

An Intrinsic Calculation For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Suggests It's 23% Undervalued

Apr 07
An Intrinsic Calculation For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Suggests It's 23% Undervalued

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable

Feb 28
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stocks Shoot Up 28% But Its P/S Still Looks Reasonable

Revenues Working Against Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Share Price

Dec 19
Revenues Working Against Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Share Price

Need To Know: Analysts Just Made A Substantial Cut To Their Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Estimates

Aug 14
Need To Know: Analysts Just Made A Substantial Cut To Their Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Estimates

Are Investors Undervaluing Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) By 27%?

Feb 28
Are Investors Undervaluing Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) By 27%?

Is Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Expensive For A Reason? A Look At Its Intrinsic Value

Nov 01
Is Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Expensive For A Reason? A Look At Its Intrinsic Value

Maravai Lifesciences temporarily reinstates Carl Hull as CEO

Oct 19

Maravai LifeSciences appoints former Danaher executive as CEO

Oct 03

Maravai LifeSciences Holdings GAAP EPS of $0.53 beats by $0.15, revenue of $242.73M beats by $9.51M

Aug 04

Estimating The Intrinsic Value Of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)

Jun 27
Estimating The Intrinsic Value Of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)

Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Intrinsic Value Is Potentially 25% Below Its Share Price

Mar 29
Maravai LifeSciences Holdings, Inc.'s (NASDAQ:MRVI) Intrinsic Value Is Potentially 25% Below Its Share Price

Maravai Faces Skeptical Investors As Pandemic Enters New Period

Jan 27

Gelir ve Gider Dağılımı

Maravai LifeSciences Holdings nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

NasdaqGS:MRVI Gelir, gider ve kazançlar (USD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 24279-13215519
31 Mar 24274-13115018
31 Dec 23289-11914717
30 Sep 234202514723
30 Jun 235447514223
31 Mar 2371815313421
31 Dec 2288322012618
30 Sep 2290723811516
30 Jun 2292024810915
31 Mar 2289522610515
31 Dec 2179918210015
30 Sep 216691501168
30 Jun 215521271088
31 Mar 21381781015
31 Dec 2028477946
31 Dec 19143-8484
31 Dec 18124-18414

Kaliteli Kazançlar: MRVI şu anda kârlı değil.

Büyüyen Kar Marjı: MRVI şu anda kârlı değil.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: MRVI kârlı değildir ve zararlar son 5 yılda yılda 28.8% oranında artmıştır.

Büyüme Hızlandırma: MRVI 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: MRVI kârlı olmadığından, geçmiş yıl kazanç büyümesinin Life Sciences sektörüyle ( -4.7% ) karşılaştırılması zorlaşıyor.


Özkaynak Getirisi

Yüksek ROE: MRVI hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -20.9% ) sahiptir.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin